Work

Therapeutic prostate cancer vaccines: a review of the latest developments.

Year: 2008

Type: article

Abstract: Therapeutic cancer vaccines are well-tolerated immunotherapy modalities designed to activate the immune system to kill cancer cells without a significant effect on healthy cells. An improved understanding of tumor immunology has led to improved strategies in vaccine development, which in turn have resulted in improved outcomes. This review discusses different types of cancer vaccines, with a focus on prostate cancer vaccines because of the high prevalence of prostate cancer and the wide variety of approaches used in prostate cancer immunotherapy.

Source: PubMed

Authors: Mahsa Mohebtash, Ravi A Madan, James L Gulley, Philip M Arlen

Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Award: Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines